Three Weekly Intra-Articular Injections of Hylan G-F 20 vs Arthrocentesis in Patients with Chronic Idiopathic Knee Osteoarthritis: A Multicenter, Evaluator- and Patient-Blinded, Randomized Controlled Trial

Bhandari, 2017, Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective, Ther Adv Musculoskelet Dis, 9, 231, 10.1177/1759720X17729641 Hunter, 2019, Osteoarthritis, Lancet, 393, 1745, 10.1016/S0140-6736(19)30417-9 Vitaloni, 2019, Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review, BMC Musculoskelet Disord, 20, 493, 10.1186/s12891-019-2895-3 Reyes, 2016, Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis: A Population-Based Cohort Study, Arthritis Rheumatol, 68, 1869, 10.1002/art.39707 Cross, 2014, The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study, Ann Rheum Dis, 73, 1323, 10.1136/annrheumdis-2013-204763 Murphy, 2008, Lifetime risk of symptomatic knee osteoarthritis, Arthritis Rheum, 59, 1207, 10.1002/art.24021 Driban, 2020, The incidence and characteristics of accelerated knee osteoarthritis among women: the Chingford cohort, BMC Musculoskelet Disord, 21, 60, 10.1186/s12891-020-3073-3 2022 2021 Hohmann, 2020, Editorial Commentary: Platelet-Rich Plasma and Hyaluronic Acid Injection for Knee Osteoarthritis Are Both Cost Effective, Arthroscopy, 36, 3079, 10.1016/j.arthro.2020.09.039 Bowden, 2021, Best-practice clinical management of flares in people with osteoarthritis: A scoping review of behavioral, lifestyle and adjunctive treatments, Semin Arthritis Rheum, 51, 749, 10.1016/j.semarthrit.2021.04.017 Cross, 2017, Defining Flare in Osteoarthritis of the Hip and Knee: A Systematic Literature Review - OMERACT Virtual Special Interest Group, J Rheumatol, 44, 1920, 10.3899/jrheum.161107 Guillemin, 2019, Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group, J Rheumatol, 46, 1188, 10.3899/jrheum.181085 Parry, 2018, Defining acute flares in knee osteoarthritis: a systematic review, BMJ Open, 8, 10.1136/bmjopen-2017-019804 Fautrel, 2005, Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA, Joint Bone Spine, 72, 235, 10.1016/j.jbspin.2004.08.009 Parry, 2017, Significant pain variability in persons with, or at high risk of, knee osteoarthritis: preliminary investigation based on secondary analysis of cohort data, BMC Musculoskelet Disord, 18, 80, 10.1186/s12891-017-1434-3 Parry, 2019, 'Acute flare-ups' in patients with, or at high risk of, knee osteoarthritis: a daily diary study with case-crossover analysis, Osteoarthritis Cartilage, 27, 1124, 10.1016/j.joca.2019.04.003 Murphy, 2015, Characterizing Pain Flares From the Perspective of Individuals With Symptomatic Knee Osteoarthritis, Arthritis Care Res (Hoboken), 67, 1103, 10.1002/acr.22545 Paskins, 2013, What influences patients with Osteoarthritis to consult their GP about their symptoms? A narrative review, BMC Family Practice, 14, 195, 10.1186/1471-2296-14-195 Thomas, 2022, Clin Geriatr Med, 38, 239, 10.1016/j.cger.2021.11.001 Maradit Kremers, 2015, Prevalence of Total Hip and Knee Replacement in the United States, J Bone Joint Surg Am, 97, 1386, 10.2106/JBJS.N.01141 Gilat, 2021, Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis, Int Orthop, 45, 345, 10.1007/s00264-020-04801-9 Maheu, 2016, Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys, Semin Arthritis Rheum, 45, S28, 10.1016/j.semarthrit.2015.11.008 Yaftali, 2019, Corticosteroids and Hyaluronic Acid Injections, Clin Sports Med, 38, 1, 10.1016/j.csm.2018.08.006 Legré-Boyer, 2015, Viscosupplementation: techniques, indications, results, Orthop Traumatol Surg Res, 101, S101, 10.1016/j.otsr.2014.07.027 Maheu, 2019, Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review, Semin Arthritis Rheum, 48, 563, 10.1016/j.semarthrit.2018.06.002 Altman, 2015, The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review, BMC musculoskeletal disorders, 16, 10.1186/s12891-015-0775-z Bannuru, 2009, Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis, Arthritis Rheum, 61, 1704, 10.1002/art.24925 Goldstein, 2015, Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies, Drug Healthc Patient Saf, 7, 31, 10.2147/DHPS.S71976 Gossec, 2006, Do intra-articular therapies work and who will benefit most?, Best Pract Res Clin Rheumatol, 20, 131, 10.1016/j.berh.2005.09.005 Hartmann, 2016, Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy, Physiol Rev, 96, 409, 10.1152/physrev.00011.2015 He, 2017, Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis, Int J Surg, 39, 95, 10.1016/j.ijsu.2017.01.087 McAlindon, 2017, Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial, Jama, 317, 1967, 10.1001/jama.2017.5283 Peng, 2005, Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs, Expert Opin Drug Saf, 4, 157, 10.1517/14740338.4.2.157 Wernecke, 2015, The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review, Orthop J Sports Med, 3, 10.1177/2325967115581163 Welsch, 2020, Opioids for chronic osteoarthritis pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks double-blind duration, Eur J Pain, 24, 685, 10.1002/ejp.1522 Chan, 2006, Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events, Circulation, 113, 1578, 10.1161/CIRCULATIONAHA.105.595793 Dinçer, 2019, NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period?, Turk J Gastroenterol, 30, 505 Olsen, 2012, Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study, Circulation, 126, 1955, 10.1161/CIRCULATIONAHA.112.112607 Trelle, 2011, Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis, BMJ, 342, c7086, 10.1136/bmj.c7086 Boscarino, 2010, Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system, Addiction, 105, 1776, 10.1111/j.1360-0443.2010.03052.x Kane-Gill, 2014, The cost of opioid-related adverse drug events, J Pain Palliat Care Pharmacother, 28, 282, 10.3109/15360288.2014.938889 Kolodny, 2015, The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction, Annu Rev Public Health, 36, 559, 10.1146/annurev-publhealth-031914-122957 Altman, 2016, Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee, Am J Sports Med, 44, 2158, 10.1177/0363546515609599 Rutjes, 2012, Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis, Ann Intern Med, 157, 180, 10.7326/0003-4819-157-3-201208070-00473 Chevalier, 2010, Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial, Ann Rheum Dis, 69, 113, 10.1136/ard.2008.094623 De Lucia, 2021, One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: a systematic literature review and meta-analysis, Clin Rheumatol, 40, 2133, 10.1007/s10067-020-05477-7 Bannuru, 2015, Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis, Ann Intern Med, 162, 46, 10.7326/M14-1231 Pham, 2004, OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited, Osteoarthritis Cartilage, 12, 389, 10.1016/j.joca.2004.02.001 Tubach, 2005, Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement, Annals of the Rheumatic Diseases, 64, 29, 10.1136/ard.2004.022905 Hummer, 2020, High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis, BMC Musculoskeletal Disorders, 21, 702, 10.1186/s12891-020-03729-w Abate, 2010, Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly, Curr Pharm Des, 16, 631, 10.2174/138161210790883859 Aggarwal, 2004, Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature, Can Fam Physician, 50, 249 Bellamy, 2006, Viscosupplementation for the treatment of osteoarthritis of the knee, Cochrane Database Syst Rev, 2006, 10.1002/14651858.CD005328.pub2 Hermans, 2019, The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial, BMC Musculoskeletal Disorders, 20, 196, 10.1186/s12891-019-2546-8 Bannuru, 2015, Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials, Ann Intern Med, 163, 365, 10.7326/M15-0623 Vannabouathong, 2018, Nonoperative Treatments for Knee Osteoarthritis: An Evaluation of Treatment Characteristics and the Intra-Articular Placebo Effect: A Systematic Review, JBJS Rev, 6, e5, 10.2106/JBJS.RVW.17.00167 Raynauld, 2005, Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis, Osteoarthritis Cartilage, 13, 111, 10.1016/j.joca.2004.10.018 Altman, 2018, Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review, Semin Arthritis Rheum, 48, 168, 10.1016/j.semarthrit.2018.01.009 Cooper, 2017, Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice, Arthritis Care Res (Hoboken), 69, 1287, 10.1002/acr.23204 Conrozier, 2021, Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group, Ther Adv Musculoskelet Dis, 13, 10.1177/1759720X211018605 Raman, 2018, Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO), Cartilage, 9, 263, 10.1177/1947603517693043 Uson, 2021, EULAR recommendations for intra-articular therapies, Ann Rheum Dis, 80, 1299, 10.1136/annrheumdis-2021-220266 Day, 2000, Blinding in clinical trials and other studies, BMJ, 321, 504, 10.1136/bmj.321.7259.504 Karanicolas, 2010, Practical tips for surgical research: blinding: who, what, when, why, how?, Can J Surg, 53, 345 Alghadir, 2018, Test–retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain, J Pain Res, 11, 851, 10.2147/JPR.S158847 Bijur, 2001, Reliability of the visual analog scale for measurement of acute pain, Acad Emerg Med, 8, 1153, 10.1111/j.1553-2712.2001.tb01132.x da Costa, 2021, Visual Analogue Scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: a meta-epidemiological study, Osteoarthritis Cartilage, 29, 304, 10.1016/j.joca.2020.10.004 Adams, 1995, The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone, Osteoarthritis Cartilage, 3, 213, 10.1016/S1063-4584(05)80013-5 Scale, 1994, Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study, Current Therapeutic Research, 55, 220, 10.1016/S0011-393X(05)80166-3 Wobig, 1998, Viscosupplementation with hylan GF 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee, Clinical therapeutics, 20, 410, 10.1016/S0149-2918(98)80052-0 Schulz, 2010, CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials, Journal of Pharmacology & Pharmacotherapeutics, 1, 100, 10.4103/0976-500X.72352 1994, A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group, JAMA, 272, 1926, 10.1001/jama.1994.03520240054041 Fazeli, 2022, Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence, Therapeutic Advances in Musculoskeletal Disease, 14, 10.1177/1759720X211066689 Saltzman, 2017, The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies, Am J Sports Med, 45, 2647, 10.1177/0363546516680607